Id,NCT Number,Study Title,Study URL,Eligibility
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
b9c610cd-28a6-4636-ccb6-c7a0d2a4cb85,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
c1f1fcaa-82fd-d5b7-3544-c8f9708b06a8,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
339144f8-50e1-633e-a013-f361391c4cff,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
d488232e-bf14-4bed-08c0-a82f34b6a197,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
217f95a3-4e10-bd5d-fb67-0cfb5e8ba075,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
faac724a-a9e9-be66-fe1e-3044dc0ba8ea,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
23d16ee3-8cd4-eeb8-e77e-1e5fbf4c4159,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
aade3c61-92bd-d079-9d28-0b2b7fde0fbb,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT04995276,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,https://clinicaltrials.gov/study/NCT04995276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
0288c42c-43a1-9878-4a9d-6b96caa12c40,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
dc6c06d0-a7d8-100f-c08b-46c93700c188,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
61a2fcc0-d679-764c-7d86-b885b2c4907f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
c0219ca9-576f-f7c2-9c44-de030e94969b,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
cb8c092a-99aa-6c9c-1ec1-660f0b00549d,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT06100276,"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)",https://clinicaltrials.gov/study/NCT06100276,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
97a20cf9-630d-939c-2f50-f13c434aee2f,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
55a6a46e-a1a4-0298-e58f-c0cb27cbb022,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
961f61f8-ed32-f113-8450-192064b49aa9,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
9acc871f-b577-5530-b8ad-fa95b58cea25,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT05690776,"PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband",https://clinicaltrials.gov/study/NCT05690776,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
1d3d0ba6-5475-07c2-0b40-562ad75fdf26,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
98e4223a-5ad8-94e0-2d73-ee5203dd4e2b,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8fa5a097-1970-9370-4193-a7baa3d235b5,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
8c2d5e9b-0717-9616-beb9-21296a5b547d,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03668327,Preterm Birth Cohort Study in Guangzhou,https://clinicaltrials.gov/study/NCT03668327,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
a7624ac9-6308-e015-1c5c-115c97c631fe,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
122b4063-18dc-f20f-204c-6f2da758717b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
33c2ca32-ae38-66c5-474f-83273568906e,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT03869476,Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.,https://clinicaltrials.gov/study/NCT03869476,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
57b53310-98a9-f011-69c0-02068c37d83b,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
c9b4f8c6-d7be-6563-0560-c90cfe6b12ca,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1f528581-7613-2b96-dce3-68c7cf967ea1,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
7024858b-f5e2-efee-8e2f-67f503fef6a5,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06113276,Quantitative Computed Tomography for Mortality Risk Stratification in ARDS,https://clinicaltrials.gov/study/NCT06113276,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
1cfa5a70-7f3c-4227-5cf1-e182fcff4cd4,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
2f031d4a-b070-ce15-6372-30c8fecf1164,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
9a632ddc-b352-6dd7-0fb3-916fde80c9a3,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
56bf1a47-8065-1ba5-6d8c-430b37a621bf,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
7d1a0d44-6f3e-2cd5-3347-0d97e5b57612,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT06597227,Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy,https://clinicaltrials.gov/study/NCT06597227,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
8bf6aa92-645f-3c82-ddcd-5851496a6aa8,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
f0660412-c40e-4d5c-5b11-08b6da289331,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
53cc5b94-3c84-3ecf-ae94-f98203e3d8ba,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT04484727,"""Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs""",https://clinicaltrials.gov/study/NCT04484727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
060e72d3-912e-55cd-0c92-5faa6cb7a6db,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
18f70d07-28a0-17f3-2605-bf21cceb194b,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
a7b903a5-5c6f-3f5e-4035-62d94b0b52b3,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
63198606-7c07-e63a-42a3-2f47419c881c,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
2dacba2b-f4f3-9726-0f13-2f1a87f69bba,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT05862727,Preschool Attention and Sleep Support (PASS),https://clinicaltrials.gov/study/NCT05862727,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
7d28d76a-9ac8-67b4-3c88-0a75be3d0851,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
307b6419-5147-4716-10b1-bb458ac191c3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
0afb59a5-12cb-3b6a-eead-3a72d24fb678,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
38565670-114d-6c46-50b9-76bbffb16ffb,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
4f5a07ca-02e0-8981-3c30-4d9924a169a3,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
6a6a1b30-9966-bd68-e732-b7ce2c0b6ade,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
be82309d-1a8f-df82-4cd6-5f03e1060e8e,NCT06286527,Quality of Sexual Life of PrEP Users,https://clinicaltrials.gov/study/NCT06286527,Not Eligible
